Responses
E-Poster viewings
Ovarian Cancer
IGCS19-0208
292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients
Compose a Response to This Article
Other responses
No responses have been published for this article.